NEW YORK ( TheStreet) -- CHANGE IN RATINGS
(CHRW) was upgraded at Stifel Nicolaus to hold from sell. Management appears to have a solid assessment of the company's positioning, Stifel Nicolaus said.
Cummins (CMI) was upgraded at Wells Fargo to outperform from market perform. Higher end-market demand should lead to a prolonged earnings growth cycle, Wells Fargo said.
Carlisle (CSL) was upgraded at BMO Capital to outperform. Twelve-month price target is $88. Company can achieve margin and ROIC targets, BMO Capital said.
DineEquity (DIN) was upgraded at Keybanc to buy from hold. Twelve-month price target is $90. Recent pullback has created an attractive buying opportunity, Keybanc said.iRobot (IRBT) was downgraded at J.P. Morgan to underweight from neutral. Valuation call, based on a $32 price target, J.P. Morgan said. Kellogg (K - Get Report) was upgraded at J.P. Morgan to neutral. Short thesis appears to have played out, J.P. Morgan said. (LULU) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $56. Bulk of the bad news appears to be behind the company, and the stock is down 43% from its highs, RBC Capital said.
MWI Veterinary (MWIV) was upgraded at Piper Jaffray to overweight from neutral. Twelve-month price target is $188. IVESCO acquisition and new products should drive growth, Piper Jaffray said.
Myriad Genetics (MYGN) was upgraded at Credit Suisse to neutral from underperform. Twelve-month price target is $29. Base business can hold up better than expected and the Crescendo purchase should add to growth, Credit Suisse said. (NBL) was upgraded at Mizuho to buy from neutral. Twelve-month price target is $78. Company has several potential catalysts, but the stock is down 17% since November, Mizuho said.